Načítá se...
Inhaled corticosteroids and the risk of type 2 diabetes among Swedish COPD patients
This study reports the association of ICS use and the risk of type 2 diabetes mellitus (T2DM) in Swedish patients with COPD using data from real-world, primary care settings. A total of 7078 patients with COPD were included in this analysis and the 5-year cumulative incidence rate per 100,000 person...
Uloženo v:
| Vydáno v: | NPJ Prim Care Respir Med |
|---|---|
| Hlavní autoři: | , , , , , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Nature Publishing Group UK
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7576803/ https://ncbi.nlm.nih.gov/pubmed/33082331 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41533-020-00207-7 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|